Building capacity and collaboration for cancer prevention


Exposure to propranolol and survival in breast cancer patients

To determine whether female breast cancer patients who are exposed to propranolol (or other non-selective beta-blockers) have reduced cancer-specific or all-cause mortality rates.

To conduct methodologically similar analyses in countries across Europe to:

  • increase power
  • investigate the consistency of any association.